AGAPE ATP CORPORATION Income (Loss) from Continuing Operations before Income Taxes, Domestic
AGAPE ATP CORPORATION (ATPC) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$142.91 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2023-08-14
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-06-30 was -$142.91K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-03-31 was -$167.78K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-12-31 was -$277.28K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-09-30 was -$165.86K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$736.95K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$706.66K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$735.16K.
- AGAPE ATP CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was -$321.81K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | -$142.91K 10-Q · filed 2023-08-14 | -$310.70K 10-Q · filed 2023-08-14 | -$587.98K derived: sum of 3 quarters · filed 2023-08-14 | -$753.84K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | -$167.78K 10-Q · filed 2023-05-15 | -$445.06K derived: sum of 2 quarters · filed 2023-05-15 | -$610.93K derived: sum of 3 quarters · filed 2023-05-15 | -$798.31K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-12-31 | -$277.28K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$443.14K derived: sum of 2 quarters · filed 2023-03-31 | -$630.52K derived: sum of 3 quarters · filed 2023-08-14 | -$736.95K 10-K · filed 2023-03-31 | |
| 2022-09-30 | -$165.86K 10-Q · filed 2022-11-14 | -$353.24K derived: sum of 2 quarters · filed 2023-08-14 | -$459.67K 10-Q · filed 2022-11-14 | -$844.76K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-06-30 | -$187.38K 10-Q · filed 2023-08-14 | -$293.80K 10-Q · filed 2023-08-14 | -$678.90K derived: sum of 3 quarters · filed 2023-08-14 | -$796.17K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$106.43K 10-Q · filed 2023-05-15 | -$491.52K derived: sum of 2 quarters · filed 2023-05-15 | -$608.79K derived: sum of 3 quarters · filed 2023-05-15 | -$705.16K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$385.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$502.36K derived: sum of 2 quarters · filed 2023-03-31 | -$598.73K derived: sum of 3 quarters · filed 2023-03-31 | -$706.66K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$117.27K 10-Q · filed 2022-11-14 | -$213.64K derived: sum of 2 quarters · filed 2022-11-14 | -$321.57K 10-Q · filed 2022-11-14 | -$655.95K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$96.37K 10-Q · filed 2022-08-11 | -$204.29K 10-Q · filed 2022-08-11 | -$538.68K derived: sum of 3 quarters · filed 2022-08-11 | -$635.28K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$107.92K 10-Q · filed 2022-05-13 | -$442.31K derived: sum of 2 quarters · filed 2022-07-05 | -$538.91K derived: sum of 3 quarters · filed 2022-07-05 | -$700.66K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-12-31 | -$334.38K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | -$430.99K derived: sum of 2 quarters · filed 2022-07-05 | -$592.74K derived: sum of 3 quarters · filed 2022-07-05 | -$735.16K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | -$96.61K 10-Q/A · filed 2022-07-05 | -$258.36K derived: sum of 2 quarters · filed 2022-07-05 | -$400.78K 10-Q/A · filed 2022-07-05 | -$594.20K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-06-30 | -$161.75K 10-Q · filed 2021-08-13 | -$304.17K 10-Q · filed 2021-08-13 | -$497.59K derived: sum of 3 quarters · filed 2021-08-13 | -$583.65K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | -$142.42K 10-Q · filed 2021-05-17 | -$335.84K derived: sum of 2 quarters · filed 2021-05-17 | -$421.89K derived: sum of 3 quarters · filed 2021-05-17 | -$449.50K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$193.42K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | -$279.48K 10-K · filed 2021-03-31 | -$307.08K derived: sum of 3 quarters · filed 2021-03-31 | -$321.81K 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$86.06K 10-Q · filed 2020-11-16 | -$113.66K derived: sum of 2 quarters · filed 2020-11-16 | -$128.39K 10-Q · filed 2020-11-16 | -$140.87K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$27.61K 10-Q · filed 2020-08-13 | -$42.33K 10-Q · filed 2020-08-13 | -$54.81K derived: sum of 3 quarters · filed 2020-08-13 | -$76.31K 10-K · filed 2020-03-27 | |
| 2019-03-31 | -$14.72K 10-Q · filed 2020-05-14 | -$27.20K derived: sum of 2 quarters · filed 2020-05-14 | -$48.70K 10-Q · filed 2019-05-13 | -$76.45K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$12.48K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | -$33.98K 10-K · filed 2020-03-27 | -$61.73K derived: sum of 3 quarters · filed 2020-03-27 | -$80.98K derived: sum of 4 quarters · filed 2020-03-27 | |
| 2018-09-30 | -$21.50K 10-Q · filed 2019-11-12 | -$49.25K derived: sum of 2 quarters · filed 2020-03-27 | -$68.50K derived: sum of 3 quarters · filed 2020-03-27 | -$192.67K derived: sum of 4 quarters · filed 2020-03-27 | |
| 2018-06-30 | -$27.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$47.00K derived: sum of 2 quarters · filed 2020-03-27 | -$171.17K derived: sum of 3 quarters · filed 2020-03-27 | -$261.92K 10-K · filed 2020-03-27 | |
| 2018-03-31 | -$19.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | -$143.42K derived: sum of 2 quarters · filed 2019-05-13 | -$234.17K 10-Q · filed 2019-05-13 | ||
| 2017-12-31 | -$124.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-15 | -$214.92K 10-Q · filed 2019-02-15 | -$212.92K 10-Q · filed 2018-02-13 | ||
| 2017-09-30 | -$90.75K 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | -$75.20K 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |